SMITH KLINE RIT has a total of 212 patent applications. Its first patent ever was published in 1973. It filed its patents most often in Australia, Japan and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are BIO VIRUS RES INC, USTAV SER A OCKOVACICH LATEK O and ENTEROVAX RES PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 21 | |
#2 | Japan | 21 | |
#3 | EPO (European Patent Office) | 20 | |
#4 | South Africa | 18 | |
#5 | Spain | 17 | |
#6 | United States | 16 | |
#7 | Denmark | 14 | |
#8 | Ireland | 13 | |
#9 | Portugal | 9 | |
#10 | Canada | 8 | |
#11 | France | 8 | |
#12 | Finland | 5 | |
#13 | United Kingdom | 4 | |
#14 | Israel | 4 | |
#15 | New Zealand | 4 | |
#16 | Hungary | 3 | |
#17 | Norway | 3 | |
#18 | Philippines | 3 | |
#19 | Greece | 2 | |
#20 | Netherlands | 2 | |
#21 | WIPO (World Intellectual Property Organization) | 2 | |
#22 | Yugoslavia (Serbia and Montenegro) | 2 | |
#23 | Argentina | 1 | |
#24 | Belgium | 1 | |
#25 | China | 1 | |
#26 | Czechoslovakia | 1 | |
#27 | Egypt | 1 | |
#28 | India | 1 | |
#29 | Jordan | 1 | |
#30 | Republic of Korea | 1 | |
#31 | African Intellectual Property Organization | 1 | |
#32 | Romania | 1 | |
#33 | USSR (Union of Socialist Soviet Republics) | 1 | |
#34 | Tunisia | 1 | |
#35 | Zimbabwe | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Machines | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Unspecified technologies | |
#5 | Climate change adaptation technologies | |
#6 | Therapeutic chemical compounds | |
#7 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Harford Nigel | 24 |
#2 | Bollen Alex Joseph | 18 |
#3 | Wilde Michel De | 18 |
#4 | Simonet Guy | 13 |
#5 | Cabezon Theresa | 12 |
#6 | De Wilde Michel | 12 |
#7 | Jacobs Paul | 12 |
#8 | Crabeel Marjolene | 11 |
#9 | Van Wijnendaele Frans | 11 |
#10 | Cabezon Teresa | 11 |
Publication | Filing date | Title |
---|---|---|
IE883483L | Expression of hiv proteins | |
IE882905L | Stable genomic integration and expression of a foreign¹coding sequence in yeast | |
IE880242L | Hepatitis b virus antigens. | |
JPS63283586A | Development of p.falciparum circumsporozoite protein by yeast | |
ZA8800488B | Hepatitis b virus surface antigens and hybrid antigens containing them | |
EP0278941A1 | Expression of the P. falciparum circumsporozoite protein by yeast | |
ZA8709286B | New plasminogen activators | |
AU7492087A | Newcastle disease virus protein | |
DK331087D0 | Stabilizer for live vaccine | |
IE871688L | Stabilizers for vaccines | |
IE871253L | Hybrid polypeptides | |
IE870537L | Purification of alpha -1-antitrypsin | |
US4714678A | Temperature sensitive strain of bovine viral diarrhoea virus | |
IE861419L | Isolation of hepatitis b surface antigen | |
US4828988A | Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine | |
US4629567A | Alpha-1-antiprotease purification | |
US4649192A | Method for the isolation and purification of hepatitis B surface antigen using polysorbate | |
US4683294A | Process for the extraction and purification of proteins from culture media producing them | |
ZA8410063B | Expression of human alpha-1-antitrypsin in yeast | |
YU171683A | Process for making hb s ag |